Clanfenur

CAS No. 51213-99-1

Clanfenur( —— )

Catalog No. M20195 CAS No. 51213-99-1

Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 88 In Stock
5MG 70 In Stock
10MG 112 In Stock
25MG 188 In Stock
50MG 277 In Stock
100MG 387 In Stock
200MG 548 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Clanfenur
  • Note
    Research use only, not for human use.
  • Brief Description
    Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
  • Description
    Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    51213-99-1
  • Formula Weight
    335.76
  • Molecular Formula
    C16H15ClFN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:soluble
  • SMILES
    CN(C)c1cccc(F)c1C(=O)NC(=O)Nc1ccc(Cl)cc1
  • Chemical Name
    N-((4-chlorophenyl)carbamoyl)-2-(dimethylamino)-6-fluorobenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jonkman-de Vries J D Bj V D B ten Bokkel-Huinink W W et al. Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur[J]. Pda J Pharm Sci Technol 1997 51(2):89-95.
molnova catalog
related products
  • β-CGRP, human TFA (1...

    β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and CRLR/RAMP2 cells.

  • Divalproex Sodium

    Divalproex Sodium binds to and inhibits gamma-aminobutyric acid (GABA) transaminase and its anticonvulsant activity may be exerted by increasing brain concentration of GABA and by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings.

  • MRE-269

    Ursonic acid belongs to the family of Ursane Triterpenes whose structure is based on the pentacyclic ursane skeleton. It has potential as HIV-1 Protease Inhibitor.